Fortress Biotech
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $14,855 | $13,030 | $19,946 | $34,752 |
Gross Profit | 8,314 | 6,214 | 13,554 | 28,323 |
EBITDA | -27,788 | -36,566 | -17,948 | -10,496 |
EBIT | -30,353 | -38,285 | -19,657 | -12,196 |
Net Income | -13,339 | -17,731 | -9,279 | -5,045 |
Net Change In Cash | 14,855 | 13,030 | 19,946 | 34,752 |
Free Cash Flow | -21,838 | -25,387 | -34,998 | -17,780 |
Cash | 76,201 | 85,837 | 80,927 | 72,307 |
Basic Shares | 18,316 | 17,151 | 10,750 | 7,498 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $84,513 | $75,743 | $68,791 | $45,599 |
Gross Profit | 55,623 | 44,968 | 36,707 | 31,005 |
EBITDA | -131,167 | -200,862 | -178,352 | -93,049 |
EBIT | -139,241 | -210,215 | -185,143 | -98,374 |
Net Income | -60,637 | -213,913 | -164,826 | -102,985 |
Net Change In Cash | 84,513 | 75,743 | 68,791 | 45,599 |
Cost of Revenue | 72,968 | 81,564 | ||
Free Cash Flow | -136,323 | -182,456 | -132,886 | -90,846 |
Cash | 80,927 | 178,266 | 305,744 | 233,351 |
Basic Shares | 8,110 | 5,924 | 5,446 | 4,800 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.73 |
2024-03-31 | -$1.03 |
2023-12-31 | -$1.28 |
2023-09-30 | -$0.94 |
